ArticleBlood2014

Cellular determinants for preclinical activity of a novel CD33/CD3 bispecific T-cell engager (BiTE) antibody, AMG 330, against human AML.

George S Laszlo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.